Our technology

Massive diversity of novel CRISPR systems targeting any genomic site of interest with high specificity, derived from a metagenomic platform based on the human microbiome.

Nuclease engineering skills to improve on target activity and specificity.

Allele specific mutation-independent editing strategy to address autosomal dominant disorders via a SNP targeting approach.